SC 13D

Company

Skye Bioscience, Inc.

Filed

August 28, 2023

Accession Number

0001104659-23-096002

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →